African American (AA) kidney transplant recipients exhibit a higher rate of graft loss compared with other racial and ethnic populations, highlighting the need to identify causative factors. Here, in the Genomics of Chronic Allograft Rejection cohort, pretransplant blood RNA sequencing revealed a cluster of four consecutive missense single-nucelotide polymorphisms (SNPs), within the leukocyte immunoglobulin-like receptor B3 (LILRB3) gene, strongly associated with death-censored graft loss. This SNP cluster (named LILRB3-4SNPs) encodes missense mutations at amino acids 617-618 proximal to a SHP1/2 phosphatase-binding immunoreceptor tyrosine-based inhibitory motif. The LILRB3-4SNPs cluster is specifically enriched within AA individuals and exhibited a strong association with death-censored graft loss and estimated glomerular filtration rate decline in the AA participants from multiple transplant cohorts. In two large Biobanks (BioMe and All-of-Us), the LILRB3-4SNPs cluster was associated with the early onset of end-stage renal disease and acted synergistically with the apolipoprotein L1 (APOL1) G1/G2 allele to accelerate disease progression. The SNPs were also linked to multiple immune-related diseases in AA individuals. Last, on multiomics analysis of blood and biopsies, recipients with LILRB3-4SNPs showed enhanced inflammation and monocyte ferroptosis. While larger and prospective studies are needed, our data provide insights on the genetic variation underlying kidney transplant outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/s41591-025-03568-z | DOI Listing |
Acta Anaesthesiol Scand
April 2025
Department of Anesthesiology and Intensive Care Medicine, Institute of Clinical Sciences at the Sahlgrenska Academy, University of Gothenburg and Section for Cardiothoracic Anesthesia and Intensive Care, Sahlgrenska University Hospital, Gothenburg, Sweden.
Background: Acute kidney injury (AKI) is a serious complication after lung transplantation, but the reported incidence varies in the literature. No data on AKI have been published from the Swedish lung transplantation program.
Methods: The aim of our study was to investigate the incidence, perioperative risk factors, and effects of early postoperative acute kidney injury (Kidney Disease Improving Global Outcomes [KDIGO] criteria) after lung transplantation.
Background: Interfering RNA therapies (RNAi) have changed the management of patients with hyperoxaluria type 1 (PH1); data in dialysis remain scarce.
Results: A PH1 teenager undergoing intensive hemodiafiltration received lumasiran. POx levels almost halved during the loading phase (98 to 52 µmol/L), but rebound occurred when doses were quarterly-spaced, with POx at 94 µmol/L at 5 months.
Nephrol Ther
March 2025
CHU de Rennes, service hospitalo-universitaire de pharmacie, Rennes, France
Nephrol Ther
March 2025
Néphrologie, hémodialyse, aphérèse et transplantation, CHU Grenoble Alpes, La Tronche, France
Eur Urol Open Sci
April 2025
Department of Urology AOU San Luigi Gonzaga, University of Turin, Orbassano, Italy.
Background And Objective: The aim of our study was to compare assessment of PADUA and RENAL nephrometry scores and risk/complexity categories via two-dimensional (2D) imaging and three-dimensional virtual models (3DVM) in a large multi-institutional cohort of renal masses suitable for robot-assisted partial nephrectomy (RAPN), and evaluate the predictive role of these imaging approaches for postoperative complications.
Methods: Patients were prospectively enrolled from six international high-volume robotic centers, calculating PADUA and RENAL-nephrometry scores and their relative categories with 2D-imaging and 3DVMs. The concordance of nephrometry scores and categories between the two approaches was evaluated using χ tests and Cohen's κ coefficient.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!